xuezhikang
Botanicalexperimental
Clinical trial activity
8 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
6
Earliest trial started Mar 1, 2010 (NCT02057302)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xuezhikang
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06750783 | Phase 4 | Dec 31, 2024 | Tsinghua University |
| NCT06093932 | Phase 4 | Dec 31, 2023 | China Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine |
| NCT05238012 | Phase 4 | Jul 1, 2022 | AstraZeneca, Capital Medical University |
| NCT02603770 | Phase 1 | Nov 1, 2015 | Luye Pharma |
| NCT02254824 | Phase 4 | Oct 1, 2013 | Capital Medical University, Chinese Academy of Medical Sciences, Peking University, Tsinghua University |
| NCT01686451 | Phase 4 | Aug 1, 2012 | Wenzhou Medical University |
| NCT01327014 | Phase 2 | Apr 1, 2011 | Peking University |
| NCT02057302 | Phase 4 | Mar 1, 2010 | China Academy of Chinese Medical Sciences |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 0 | 1 | 2013 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2010 |
| Peking University | Academic/Hospital | 2 | 1 | 2 | 2011 |
| Tsinghua University | Academic/Hospital | 2 | 1 | 1 | 2013 |
| AstraZeneca | For profit | 1 | 0 | 1 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Luye Pharma | For profit | 1 | 1 | 1 | 2015 |
| Shandong University of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Wenzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2012 |
9 organizations
Page 1 / 1